These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9310468)

  • 1. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
    Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
    Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
    Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM
    Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin receptor and STAT5-specific pathways promote SKT6 cell hemoglobinization.
    Gregory RC; Jiang N; Todokoro K; Crouse J; Pacifici RE; Wojchowski DM
    Blood; 1998 Aug; 92(4):1104-18. PubMed ID: 9694697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
    Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
    Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line.
    Iwatsuki K; Endo T; Misawa H; Yokouchi M; Matsumoto A; Ohtsubo M; Mori KJ; Yoshimura A
    J Biol Chem; 1997 Mar; 272(13):8149-52. PubMed ID: 9079629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites.
    Yi T; Zhang J; Miura O; Ihle JN
    Blood; 1995 Jan; 85(1):87-95. PubMed ID: 7528577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms.
    Miller CP; Heilman DW; Wojchowski DM
    Blood; 2002 Feb; 99(3):898-904. PubMed ID: 11806992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.
    Ogilvie M; Yu X; Nicolas-Metral V; Pulido SM; Liu C; Ruegg UT; Noguchi CT
    J Biol Chem; 2000 Dec; 275(50):39754-61. PubMed ID: 10995753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
    Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
    Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHP1 protein tyrosine phosphatase negatively modulates erythroid differentiation and suppression of apoptosis in J2E erythroleukemic cells.
    Bittorf T; Seiler J; Zhang Z; Jaster R; Brock J
    Biol Chem; 1999 Oct; 380(10):1201-9. PubMed ID: 10595583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.
    Klingmüller U; Lorenz U; Cantley LC; Neel BG; Lodish HF
    Cell; 1995 Mar; 80(5):729-38. PubMed ID: 7889566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5.
    Okajima Y; Matsumura I; Nishiura T; Hashimoto K; Yoshida H; Ishikawa J; Wakao H; Yoshimura A; Kanakura Y; Tomiyama Y; Matsuzawa Y
    J Biol Chem; 1998 Sep; 273(36):22877-83. PubMed ID: 9722506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
    Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
    Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
    Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
    Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.